There was no specific reason to select these two cell lines except that p53 loss and KRAS-G12D mutation represented oncogenic changes that are relevant to promotion of cancer growth and that these cell lines showed the greatest activity for the respective transporters. The gene discussed is KRAS; the disease is cancer.